Harmony Biosciences Holdings (HRMY) Tax Rate Growth (1y) (2022 - 2026)

Harmony Biosciences Holdings (HRMY) Tax Rate Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Harmony Biosciences Holdings 2.09 Bn 1.57 Bn 170.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -218.00
Dec 31, 2025 -7,201.00
Sep 30, 2025 -123.00
Jun 30, 2025 -2,670.00
Mar 31, 2025 -566.00
Dec 31, 2024 -2,107.00
Sep 30, 2024 6.00
Jun 30, 2024 2,436.00
Mar 31, 2024 402.00
Dec 31, 2023 4,295.00
Sep 30, 2023 102,964.00
Jun 30, 2023 271.00
Mar 31, 2023 1,383.00
Dec 31, 2022 -1,719.00
Sep 30, 2022 -101,241.00
Jun 30, 2022 724.00